Mid-term follow-up after COVID-19 vaccination in adults with CHD: a prospective study.

Flavia FuscoGiancarlo ScognamiglioAnna Selvaggia RomaMassimiliana AbbateGiovanni PapaccioliAssunta MerolaMichela PalmaNunzia BorrelliRosaria BarracanoAnna CorreraNicola GrimaldiGiovanni Domenico CirielloMaurizio D'AbbraccioCristina ScavoneAnnalisa CapuanoBerardo Sarubbi

Published in: Cardiology in the young (2023)

COVID-19 vaccines appear safe in the mid-term follow-up in adults with CHD with satisfactory immunogenicity and reduction of symptoms' duration in case of infection.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
depressive symptoms